This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A look at the current standard of care of meningitis and the potential of MenABCWY - an investigational pentavalent vaccine - in anticipation of an approval application by Pfizer after the success of the phase 3 trial

Ticker(s): PFE

Who's the expert?

Institution: Optum

  • Urgent Care  Lead Clinician at Optum 
  • Familiar with the phase 3 MenABCWY Noninferiority study
  • Manages 10 patients in the ER with Meningitis 

Interview Goal
This conversation will focus on the potential of MenABCWY - an investigational pentavalent vaccine for meningitis

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.